No, they don't need him. It was probably agreed to in order to avoid a lawsuit. He's consulting and that's it. You can be sure he will have no part of day-to-day issues. And frankly, you'd better pray the company lets him nowhere near the FDA.
I would think about it over a 12-pack and a few hot dogs. Then after I was drunk and full, I'd take the deal, but possibly because I was drunk and feeling good from eating all of those hot dogs.
I think it has as much to do with momentum waning and swing/day traders selling to move onto other stocks. I think it'll probably range trade for a few weeks building a nice base and then start heading higher at the end of the month as the FDA's decision draws near. Guess we'll see.
I think they'll probably take 60 days. Mainly because it's the FDA and they're a bureaucracy just like all government agencies. But who knows, maybe Henri was hired in part to help with the FDA process. One has to assume he knows his way around there.
That makes sense too. I would prefer a partnership, and if the company isn't sold, I think it's more than likely they partner eteplirsen for exon-51. We should have done so a long time ago, truthfully. Even if we partner eteplirsen for exon-51, we'll still be fine and the money we generate will be more than enough for the company to tackle the rest of the exons as well as the remaining pipeline. Wall Street would be happy to see SRPT partner with a big pharma, and it would shut the shorts up once and for all.
I don't think a sale would come until after Advisory Committee votes, but wouldn't be surprised to see it before approval. The value of the company goes way, way up on Adcom recommending approval, so I don't think the company would be silly enough to sell before that. Rest assured, if the FDA files the NDA in August, there will be an Adcom, and it will be positive.
The FDA will most certainly have data on these new boys and no doubt that many of their parents will speak up as well. The advocacy for eteplirsen will be huge, PPMD on board or not.
I could be completely wrong, and it does make sense that the BBJ would expect him to disclose any holdings. But he writes a lot about SRPT shorts on his twitter feed, which is odd for someone not actually playing the stock.
Personally, I take everything Don Sieffert writes with a grain of salt. I don't think he's a terribly good journalist because he doesn't add clarity to his writing, and sometimes--as in this case--he's flat out wrong.
Has anybody ever asked if he owns SRPT stock? Because I'd wager heavily that he does. If so, he needs to disclose this info because it most certainly influences his writing.
Stop injecting objectivity into the discussion! We'd rather be blind!!!!!!!!!!!!!
Yup. Shorts were absolutely ticked about today's news and pounded the share price down. Was bound to happen. They'll be up a shytt creek without a paddle soon enough.